loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Ciforadenant

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Ciforadenant

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corvus Pharma Announces Initiation of Phase 1b/2 Clinical Trial of Ciforadenant
    Corvus Pharma Announces Initiation of Phase 1b/2 Clinical Trial of Ciforadenant

    25 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/25/2541307/0/en/Corvus-Pharmaceuticals-Announces-Initiation-of-Phase-1b-2-Clinical-Trial-of-Ciforadenant-as-Potential-First-Line-Treatment-for-Patients-with-Renal-Cell-Cancer.html

    GLOBENEWSWIRE
    25 Oct 2022
    Share Share
    Corvus to Present Data on Refinement of the Adenosine Gene Signature
    Corvus to Present Data on Refinement of the Adenosine Gene Signature

    13 May 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/05/13/2033077/0/en/Corvus-Pharmaceuticals-to-Present-Data-on-Refinement-of-the-Adenosine-Gene-Signature-and-Ciforadenant-in-Renal-Cell-Cancer-at-the-ASCO20-Virtual-Scientific-Program.html

    GLOBENEWSWIRE
    13 May 2020
    Share Share